Search Results for: ESR1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
DHX9 DExH-box helicase 9
  • RIP-mediated NFkB activation via ZBP1
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • mRNA Splicing - Major Pathway
EPRS1 glutamyl-prolyl-tRNA synthetase 1
  • Selenoamino acid metabolism
  • Cytosolic tRNA aminoacylation
  • tRNA modification in the nucleus and cytosol
  • Glutamic acid
  • Proline
  • 5'-O-(L-Prolylsulfamoyl)adenosine
  • 5'-O-(L-Cysteinylsulfamoyl)adenosine
  • 5'-O-(N-(Alanyl)sulfamoyl)adenosine
FKBP5 FKBP prolyl isomerase 5
  • HSP90 chaperone cycle for steroid hormone receptors (SHR)
  • ESR-mediated signaling
  • MECP2 regulates neuronal receptors and channels
HNRNPA1 heterogeneous nuclear ribonucleoprotein A1
  • FGFR2 alternative splicing
  • mRNA Splicing - Major Pathway
  • Processing of Capped Intron-Containing Pre-mRNA
HNRNPA2B1 heterogeneous nuclear ribonucleoprotein A2/B1
  • mRNA Splicing - Major Pathway
  • Processing of Capped Intron-Containing Pre-mRNA
  • Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
  • Copper
  • Artenimol
HNRNPC heterogeneous nuclear ribonucleoprotein C
  • SUMOylation of RNA binding proteins
  • mRNA Splicing - Major Pathway
  • Processing of Capped Intron-Containing Pre-mRNA
JUND JunD proto-oncogene, AP-1 transcription factor subunit
  • Estrogen-dependent gene expression
  • NGF-stimulated transcription
  • NGF-stimulated transcription
KARS1 lysyl-tRNA synthetase 1
  • Selenoamino acid metabolism
  • Cytosolic tRNA aminoacylation
  • Mitochondrial tRNA aminoacylation
  • L-Lysine
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
MED21 mediator complex subunit 21
  • PPARA activates gene expression
  • Transcriptional regulation of white adipocyte differentiation
  • Transcriptional regulation of white adipocyte differentiation
MPG N-methylpurine DNA glycosylase
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Cleavage of the damaged purine
  • Displacement of DNA glycosylase by APEX1
  • Cisplatin
  • Zinc
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
NPPA natriuretic peptide A
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • Physiological factors
  • Amyloid fiber formation
  • Atrial fibrillation
RACK1 receptor for activated C kinase 1
  • Regulation of TNFR1 signaling
  • TNFR1-induced NFkappaB signaling pathway
  • TNFR1-mediated ceramide production
  • Copper
RANBP9 RAN binding protein 9
  • L1CAM interactions
  • RAF/MAP kinase cascade
  • MET activates RAS signaling
SARNP SAP domain containing ribonucleoprotein
  • Transport of Mature mRNA derived from an Intron-Containing Transcript
  • mRNA 3'-end processing
  • RNA Polymerase II Transcription Termination
TAP1 transporter 1, ATP binding cassette subfamily B member
  • ER-Phagosome pathway
  • ER-Phagosome pathway
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Bare lymphocyte syndrome (BLS) type1
  • Combined immunodeficiencies (CIDs), including the following nine diseases: X-linked hyper IgM syndrome; CD40 deficiency hyper IgM syndrome; Purine nucleoside phosphorylase (PNP) deficiency; Omenn syndrome; MHC deficiency (HLA-class I); MHC deficiency (HLA-class II); Zap-70 deficiency; p56 Lck deficiency; CD8 deficiency
TNFRSF14 TNF receptor superfamily member 14
  • Costimulation by the CD28 family
  • Costimulation by the CD28 family
  • TNFs bind their physiological receptors
TRIM24 tripartite motif containing 24
  • Signaling by cytosolic FGFR1 fusion mutants
  • Signaling by FGFR1 in disease
  • Signaling by BRAF and RAF fusions
TRIM28 tripartite motif containing 28
  • Generic Transcription Pathway
  • SUMOylation of transcription cofactors
  • HCMV Early Events
ACTN4 actinin alpha 4
  • Platelet degranulation
  • Nephrin family interactions
  • Nephrotic syndrome and focal segmental glomerulosclerosis
ARID1A AT-rich interaction domain 1A
  • RMTs methylate histone arginines
  • RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known

Page 11 out of 19 pages